Comparative biomarker analysis of PALOMA-2/3 trials for palbociclib.
Saved in:
| Title: | Comparative biomarker analysis of PALOMA-2/3 trials for palbociclib. |
|---|---|
| Authors: | Zhu Z; Pfizer Inc, La Jolla, CA, USA., Turner NC; Royal Marsden Hospital and Institute of Cancer Research, London, UK. nick.turner@icr.ac.uk., Loi S; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., André F; Institut Gustave Roussy, INSERM and Université Paris Saclay, Villejuif, France., Martin M; Instituto para la Investigación Sanitaria Gregorio Marañón, Ciberonc, Universidad Complutense, Madrid, Spain., Diéras V; Centre Eugène Marquis, Rennes Cedex, France., Gelmon KA; British Columbia Cancer, Vancouver, BC, Canada., Harbeck N; Brustzentrum der Universität München (LMU), München, Germany., Zhang C; Pfizer Inc, La Jolla, CA, USA., Cao JQ; Pfizer Inc, La Jolla, CA, USA., Yan Z; Pfizer Inc, La Jolla, CA, USA., Lu DR; Pfizer Inc, La Jolla, CA, USA., Wei P; Pfizer Inc, La Jolla, CA, USA., VanArsdale TL; Pfizer Inc, La Jolla, CA, USA., Rejto PA; Pfizer Inc, La Jolla, CA, USA., Huang X; Pfizer Inc, La Jolla, CA, USA., Rugo HS; University of California San Francisco Helen Diller Comprehensive Center, San Francisco, CA, USA., Loibl S; German Breast Group, Neu-Isenburg, Germany., Cristofanilli M; Weill Cornell Medicine, New York, NY, USA., Finn RS; David Geffen School of Medicine at UCLA, Santa Monica, CA, USA., Liu Y; Pfizer Inc, La Jolla, CA, USA. |
| Source: | NPJ precision oncology [NPJ Precis Oncol] 2022 Aug 16; Vol. 6 (1), pp. 56. Date of Electronic Publication: 2022 Aug 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35974168 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Comparative biomarker analysis of PALOMA-2/3 trials for palbociclib. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zhu+Z%22">Zhu Z</searchLink>; Pfizer Inc, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Turner+NC%22">Turner NC</searchLink>; Royal Marsden Hospital and Institute of Cancer Research, London, UK. nick.turner@icr.ac.uk.<br /><searchLink fieldCode="AU" term="%22Loi+S%22">Loi S</searchLink>; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22André+F%22">André F</searchLink>; Institut Gustave Roussy, INSERM and Université Paris Saclay, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Martin+M%22">Martin M</searchLink>; Instituto para la Investigación Sanitaria Gregorio Marañón, Ciberonc, Universidad Complutense, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Diéras+V%22">Diéras V</searchLink>; Centre Eugène Marquis, Rennes Cedex, France.<br /><searchLink fieldCode="AU" term="%22Gelmon+KA%22">Gelmon KA</searchLink>; British Columbia Cancer, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Harbeck+N%22">Harbeck N</searchLink>; Brustzentrum der Universität München (LMU), München, Germany.<br /><searchLink fieldCode="AU" term="%22Zhang+C%22">Zhang C</searchLink>; Pfizer Inc, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Cao+JQ%22">Cao JQ</searchLink>; Pfizer Inc, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Yan+Z%22">Yan Z</searchLink>; Pfizer Inc, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lu+DR%22">Lu DR</searchLink>; Pfizer Inc, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Wei+P%22">Wei P</searchLink>; Pfizer Inc, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22VanArsdale+TL%22">VanArsdale TL</searchLink>; Pfizer Inc, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Rejto+PA%22">Rejto PA</searchLink>; Pfizer Inc, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Huang+X%22">Huang X</searchLink>; Pfizer Inc, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Rugo+HS%22">Rugo HS</searchLink>; University of California San Francisco Helen Diller Comprehensive Center, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Loibl+S%22">Loibl S</searchLink>; German Breast Group, Neu-Isenburg, Germany.<br /><searchLink fieldCode="AU" term="%22Cristofanilli+M%22">Cristofanilli M</searchLink>; Weill Cornell Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Finn+RS%22">Finn RS</searchLink>; David Geffen School of Medicine at UCLA, Santa Monica, CA, USA.<br /><searchLink fieldCode="AU" term="%22Liu+Y%22">Liu Y</searchLink>; Pfizer Inc, La Jolla, CA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101708166%22">NPJ precision oncology</searchLink> [NPJ Precis Oncol] 2022 Aug 16; Vol. 6 (1), pp. 56. <i>Date of Electronic Publication: </i>2022 Aug 16. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature%22">Springer Nature </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101708166 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2397-768X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222397768X%22">2397768X </searchLink><i>NLM ISO Abbreviation: </i>NPJ Precis Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35974168 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41698-022-00297-1 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 56 Titles: – TitleFull: Comparative biomarker analysis of PALOMA-2/3 trials for palbociclib. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zhu Z – PersonEntity: Name: NameFull: Turner NC – PersonEntity: Name: NameFull: Loi S – PersonEntity: Name: NameFull: André F – PersonEntity: Name: NameFull: Martin M – PersonEntity: Name: NameFull: Diéras V – PersonEntity: Name: NameFull: Gelmon KA – PersonEntity: Name: NameFull: Harbeck N – PersonEntity: Name: NameFull: Zhang C – PersonEntity: Name: NameFull: Cao JQ – PersonEntity: Name: NameFull: Yan Z – PersonEntity: Name: NameFull: Lu DR – PersonEntity: Name: NameFull: Wei P – PersonEntity: Name: NameFull: VanArsdale TL – PersonEntity: Name: NameFull: Rejto PA – PersonEntity: Name: NameFull: Huang X – PersonEntity: Name: NameFull: Rugo HS – PersonEntity: Name: NameFull: Loibl S – PersonEntity: Name: NameFull: Cristofanilli M – PersonEntity: Name: NameFull: Finn RS – PersonEntity: Name: NameFull: Liu Y IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 08 Text: 2022 Aug 16 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 2397-768X Numbering: – Type: volume Value: 6 – Type: issue Value: 1 Titles: – TitleFull: NPJ precision oncology Type: main |
| ResultId | 1 |